Parasitic infections are the major concern of health among animals. Poultry, swine, ruminants and other domesticated animals are affected by several parasites including worms, coccidia, giardia and physalopetra among others. Coccidia are a class of protozoic parasites that are singe-celled tiny organisms. These microbes affect the intestinal tracts of the animals and the infection caused by these protozoa is called as coccidiosis. Coccidiosis is one of the most prevalent parasitic diseases of domesticated animals, and its symptoms include weight loss, mild intermittent to severe diarrhea, and feces containing blood or mucus, dehydration, and reduced breeding.
Anticoccidial drugs are medical formulations that are used for the treatment of coccidiosis in animals. These are administered into animals and birds to prevent the replication of coccidia and kill the protozoa in the intestine. Anticoccidial drugs play an essential role in the prevention and treatment of coccidiosis. The increasing incidences of coccidiosis are giving the key players lucrative opportunities to manufacture the anticoccidial drugs over the period of forecast.
Market Dynamics
Drivers
-
High prevalence of coccidiosis and its economic impact
-
Development of novel formulations
Restraints
-
Stringent regulatory requirements
-
Rising use of vaccination against coccidiosis
Market Segmentation
The development of Ionophore anticoccidial drugs in 1972 marked a major breakthrough in the field of animal antibiotics and animal health. Ionophores are the most widely used category of Anticoccidials globally, accounting for a share of 57.8% in terms of dollar sales in 2018. These are fermentation products of Streptomyces spp. and Actinomadura spp. There are large number of ionophores used as Anticoccidials in maintenance of animal health. Salinomycin, Monensin and Lasalocid are the major ionophores currently available in the market.
The global sales of Ionophore Anticoccidial drugs valued USD 570.6 million in 2018 and is estimated to reach USD 860.4 million by 2026, growing at a CAGR of 5.3% during 2019-2026
Poultry is the largest application species of anticoccidial drugs holding a share of 44.8% in the dollar sales of the global anticoccidial drugs market. Control of parasitic infections is of utmost importance in the poultry industry as these diseases pose severe impact on the overall productivity and profitability of the process. Anticoccidials are one of the major anti-parasites among broilers, breeders, turkey and chicks.
These solutions are used in treatment and prevention of coccidial infection and are fed to poultry birds through feed intake. Also, these compounds enhance feed efficiency and help increase the weight of the bird, thereby providing economic benefits to the farmers. The high economic impact of coccidial infections in the poultry farming industry is promoting the growth of the global poultry anticoccidial drugs market.
Geographical Analysis
Asia Pacific is one of the promising markets for anticoccidial drugs owing to the promising growth rate in countries such as India and Indonesia. Poultry and cattle are the leading segments of the market by animal type. Coccidiosis is one of the most severe parasitic diseases in broiler chickens in India, China and other major poultry producing countries.
The market for Anticoccidial drugs in Asia Pacific region valued USD 255.7 million in 2018 and is estimated to reach USD 380.0 million in 2026, by growing at a CAGR of 5.1% during 2019-2026
The rising poultry production coupled with increasing demand for egg and chicken meat will support the market growth. Feed production and consumption is also witnessing significant growth. According to poultry industry estimates, the global poultry consumption is likely to increase 20% by 2037 and Asia is estimated to spur 40% of this growth potential. Layer and broiler poultry feed production in the region is reported as 73.14 MMT and 115.2 MMT respectively in 2019. Layer feed witnessed an annual growth of 7% which is significantly grater than the global growth of 4%.
Notable Players
-
Phibro Animal Health Corporation
-
Zoetis Inc.
-
Elanco Animal Health
-
Vetline India
-
Virbac
-
Vetoquinol S.A.
-
Kepro B.V.
-
Provet Pharma Private Limited
-
Bayer AG
-
Pharmavet
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866
Website: www.datamintelligence.com
